[1]
Bazzichi, L. et al. 2014. Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study. Reumatismo. 66, 3 (Nov. 2014), 224–232. DOI:https://doi.org/10.4081/reumatismo.2014.748.